Updates from the Citron team
Corvention Clears FDA for UHP Balloon
Corvention, a structural heart medical device company based in Flagstaff, Arizona, received 510(k) clearance from the FDA for its KardiaPSI Balloon Catheter on May 11, 2026. The device is indicated for balloon aortic valvuloplasty and delivers 24 atm in a 2.5 cm working length, intended for dilation of calcified stenotic aortic valves.
Read moreJunkosha has announced the winners of its 2026 Technology Innovator of the Year Award, recognizing device developers pushing the boundaries of catheter and minimally invasive device design.
Read moreUlbrich Stainless Steels & Special Metals is investing $9 million in new equipment at its Wallingford, Connecticut headquarters. The expansion, covered by both CBIA and the Hartford Business Journal, signals continued growth for the precision metals manufacturer.
Read moreA better way to source medical device components
We built Citron to fix how R&D engineers find the tubing, wire, and coatings they need. Here's what we're doing and why.
Read more